Pharmacoeconomics, 1170-7690

Journal

  1. 2019
  2. 2018
  3. Makady, A., van Veelen, A., Jonsson, P., Moseley, O., D'Andon, A., de Boer, A., ... Goettsch, W. (2018). Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies. Pharmacoeconomics, 36(3), 359-368. https://doi.org/10.1007/s40273-017-0596-z
  4. 2017
  5. 2016
  6. Dunlop, W. C. N., Mullins, C. D., Pirk, O., Goeree, R., Postma, M. J., Enstone, A., & Heron, L. (2016). BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles. Pharmacoeconomics, 34(10), 1051-1065. https://doi.org/10.1007/s40273-016-0427-7
  7. Bindels, J., Ramaekers, B., Ramos, I. C., Mohseninejad, L., Knies, S., Grutters, J., ... Joore, M. (2016). Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives. Pharmacoeconomics, 34(3), 315-322. https://doi.org/10.1007/s40273-015-0346-z
  8. 2015
  9. Marshall, D. A., Burgos-Liz, L., Pasupathy, K. S., Padula, W. V., IJzerman, M. J., Wong, P. K., ... Osgood, N. D. (2015). Transforming Healthcare Delivery: Integrating Dynamic Simulation Modelling and Big Data in Health Economics and Outcomes Research. Pharmacoeconomics. https://doi.org/10.1007/s40273-015-0330-7
  10. 2014
  11. 2013
  12. 2012
  13. 2011
  14. van Baal, P. H. M., Wong, A., Slobbe, L. C. J., Polder, J. J., Brouwer, W. B. F., & de Wit, G. A. (2011). Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations. Pharmacoeconomics, 29(3), 175-187.
  15. 2009
  16. Van Asselt, A. D. I., Van Mastrigt, G. A. P. G., Dirksen, C. D., Arntz, A., Severens, J. L., & Kessels, A. G. H. (2009). How to deal with cost differences at baseline. Pharmacoeconomics, 27(6), 519-528. https://doi.org/10.2165/00019053-200927060-00007
  17. 2008
  18. de Vries, R., Daenen, S., Tolley, K., Glasmacher, A., Prentice, A., Howells, S., ... Postma, M. J. (2008). Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections. Pharmacoeconomics, 26(1), 75-90.
  19. Heeg, B. M. S., Damen, J., Buskens, E., Caleo, S., de Charro, F., & van Hout, B. A. (2008). Modelling approaches - The case of schizophrenia: the case of schizophrenia. Pharmacoeconomics, 26(8), 633-648.
  20. 2007
  21. 2006
  22. Oude Voshaar, R. C., Krabbe, P. F. M., Gorgels, W. J. M. J., Adang, E. M. M., van Balkom, A. J. L. M., van de Lisdonk, E. H., & Zitman, F. G. (2006). Tapering off benzodiazepines in long-term users: an economic evaluation. Pharmacoeconomics, 24(7), 683-694.
  23. 2005
  24. 2004
  25. Tramarin, A., Campostrini, S., Postma, M., Calleri, G., Tolley, K., Parise, N., & de Lalla, F. (2004). A Multicentre Study of Patient Survival, Disability, Quality of life and Cost of Care. Pharmacoeconomics, 22(1), 43 - 53.
  26. Tramarin, A., Campostrini, S., Postma, MJ., Calleri, G., Tolley, K., Parise, N., ... Palladio Study Grp (2004). A multicentre study of patient survival, disability, quality of life and cost of care - Among patients with AIDS in northern Italy. Pharmacoeconomics, 22(1), 43-53.
Previous 1 2 Next

ID: 729269